Business ❯Pharmaceutical Industry

Market Trends

Drug Pricing Pricing Strategies Stock Performance Drug Development Weight Loss Drugs Novo Nordisk Drug Competition Consumer Behavior Drug Sales Sales Performance Drug Adoption Rates Drug Research Celebrity Endorsements Drug Shortages Investment Weight-loss Market CBD Market Drug Launches Investment Impact Product Packaging Sustainability Obesity Treatments Product Launches Revenue Growth Stock Prices Weight Loss Drug Market Online Pharmacies Drug Production Investor Insights Drug Demand Obesity Drugs Market Investor Sentiment Sales Growth Consumer Genetics Healthcare Costs Obesity Drug Market

U.S. Drug Launch Prices Skyrocket, Driven by Rare Disease Treatments

The median price of new drugs exceeded $370,000 in 2024, with single-dose gene therapies reaching as high as $4.25 million.

Counterfeit Ozempic Pens and Prescription Forgeries Raise Alarm in Germany

PAMI Updates Drug Subsidy Program with New Eligibility Rules and Full Coverage for Critical Treatments

Eli Lilly's Oral GLP-1 Pill Demonstrates Success in Phase 3 Trials

UK Grants First Global Approval for GSK’s Blenrep in Two Combination Therapies

Pfizer Halts Development of Oral Weight-Loss Pill After Liver Injury

FDA Launches Roadmap to Phase Out Animal Testing in Drug Development

Eli Lilly's Mounjaro Launches in India, Targeting Obesity and Diabetes

Rising Use of Ozempic Raises Health, Ethical, and Social Concerns

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

Taxpayer-Funded Weight-Loss Drugs Face Scrutiny Over High Prices

Weight Loss Industry Transformed by New Drugs and Emerging Alternatives

Growing Demand for Weight-Loss Drugs in the UK Raises Safety and Accessibility Concerns

U.S. Obesity Rates Decline for First Time in Over a Decade

Amgen's Weight-Loss Drug Shows Promise but Faces Investor Skepticism

Reproductive Health Product Sales Surge Post-Trump Election Win

Limited Access to Popular Weight-Loss Drugs Highlights Socioeconomic Disparities

Supply and Cost Challenges Persist for Popular Weight-Loss Drugs

Cost and Efficacy Concerns Arise for GLP-1 Weight Loss Drugs

Bernie Sanders Pushes for Cheaper Ozempic Amid Medicare Price Negotiations